Skip to main content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Guidance for cancer researchers: https://www.cancer.gov/coronavirus-researchers

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.covid19.nih.gov

Grant Details

Grant Number: 7R01AR054983-05 Interpret this number
Primary Investigator: Chren, Mary-Margaret
Organization: University Of California, San Francisco
Project Title: Long-Term Outcomes of Nonmelanoma Skin Cancer
Fiscal Year: 2009


Abstract

DESCRIPTION (provided by applicant): Nonmelanoma skin cancer is the most frequent malignancy, with an incidence exceeding that of all noncutaneous malignancies combined. The conventional goal of therapy is removal of the primary cancer and prevention of its recurrence, a long-term outcome that cannot be assessed adequately before five years after therapy. For most tumors, many therapies can prevent recurrence, and although therapies vary in cost, existing data are insufficient to permit evidence-based choices among therapies. We have assembled and followed a consecutive cohort of patients with nonmelanoma skin cancer (NMSC) to determine their short- term, patient-reported outcomes. We have learned that two therapies that vary widely in cost and are used differently in different settings nonetheless have similar in short-term outcomes, including quality-of-life. This project will build on this previous work, by determining long-term outcomes, including tumor recurrence. Objective and Specific Aims. To determine the effectiveness of therapies for nonmelanoma skin cancer by comparing long-term tumor recurrence rates and quality of life after treatments. This application proposes a prospective longitudinal study of a cohort of patients assembled at the time of diagnosis of NMSC. The cohort consists of all 1545 patients with new primary NMSC diagnosed in 1999-2000 at two large dermatology practices. In this project we will compare outcomes from the three most common therapies, tumor destruction with electrodessication & curettage, excision, and Mohs surgery. The primary outcome is tumor recurrence at a minimum of five years after therapy; a secondary outcome is skin-related quality of life. We hypothesize that tumor recurrence will be highest after electrodessication & curettage, and similar after excision and Mohs surgery. Principal sources of data are patient examination, medical records, and patient responses to surveys. Analyses. Mixed effects generalized linear models will be used to model the effect of treatment on outcomes, adjusting for patient, tumor, and clinician factors that might likely have affected tumor recurrence and quality of life at five years after therapy. Multivariate Cox proportional hazards models will also be used to explore the distribution of time to detection of first tumor recurrence. Relevance to Public Health. Given the high prevalence of NMSC, effectiveness of therapies is important, but poorly understood. This project will evaluate effectiveness of therapies in preventing tumor recurrence and improving quality of life in a valuable consecutive cohort on whom high-fidelity baseline clinical and patient-reported data are available. Results will inform clinicians by permitting therapeutic choices that are more directly based on evidence. The results will also provide a basis for planning controlled trials of different treatments of NMSC, to guide decisions about the use of resources for this common tumor.



Publications

All-cause mortality in patients with basal and squamous cell carcinoma: A systematic review and meta-analysis.
Authors: Wehner M.R. , Cidre Serrano W. , Nosrati A. , Schoen P.M. , Chren M.M. , Boscardin J. , Linos E. .
Source: Journal of the American Academy of Dermatology, 2018 04; 78(4), p. 663-672.e3.
EPub date: 2017-11-13.
PMID: 29146125
Related Citations

Tumor recurrence of keratinocyte carcinomas judged appropriate for Mohs micrographic surgery using Appropriate Use Criteria.
Authors: Stuart S.E. , Schoen P. , Jin C. , Parvataneni R. , Arron S. , Linos E. , Boscardin W.J. , Chren M.M. .
Source: Journal of the American Academy of Dermatology, 2017 Jun; 76(6), p. 1131-1138.e1.
EPub date: 2017-03-29.
PMID: 28365039
Related Citations

Skin Cancer in U.S. Elderly Adults: Does Life Expectancy Play a Role in Treatment Decisions?
Authors: Linos E. , Chren M.M. , Stijacic Cenzer I. , Covinsky K.E. .
Source: Journal of the American Geriatrics Society, 2016 08; 64(8), p. 1610-5.
EPub date: 2016-06-15.
PMID: 27303932
Related Citations

'What is it about your skin cancer that bothers you the most?': 700 patients respond.
Authors: Grewal S.K. , Chren M.M. , Parvataneni R. , Stuart S.E. , Galles E. , Linos E. .
Source: The British journal of dermatology, 2015 Jul; 173(1), p. 296-7.
EPub date: 2015-05-21.
PMID: 25523523
Related Citations

Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma.
Authors: Wehner M.R. , Linos E. , Parvataneni R. , Stuart S.E. , Boscardin W.J. , Chren M.M. .
Source: JAMA dermatology, 2015 Apr; 151(4), p. 382-8.
PMID: 25588079
Related Citations

Patient-reported outcomes of electrodessication and curettage for treatment of nonmelanoma skin cancer.
Authors: Galles E. , Parvataneni R. , Stuart S.E. , Linos E. , Grewal S. , Chren M.M. .
Source: Journal of the American Academy of Dermatology, 2014 Nov; 71(5), p. 1026-8.
EPub date: 2014-10-15.
PMID: 25437972
Related Citations

International prevalence of indoor tanning: a systematic review and meta-analysis.
Authors: Wehner M.R. , Chren M.M. , Nameth D. , Choudhry A. , Gaskins M. , Nead K.T. , Boscardin W.J. , Linos E. .
Source: JAMA dermatology, 2014 Apr; 150(4), p. 390-400.
PMID: 24477278
Related Citations

Response to Rogers et al.
Authors: Chren M.M. .
Source: The Journal of investigative dermatology, 2014 Apr; 134(4), p. 1135-1136.
EPub date: 2013-11-12.
PMID: 24217013
Related Citations

Treatment of nonfatal conditions at the end of life: nonmelanoma skin cancer.
Authors: Linos E. , Parvataneni R. , Stuart S.E. , Boscardin W.J. , Landefeld C.S. , Chren M.M. .
Source: JAMA internal medicine, 2013-06-10; 173(11), p. 1006-12.
PMID: 23699934
Related Citations

Rerecurrence 5 years after treatment of recurrent cutaneous basal cell and squamous cell carcinoma.
Authors: Hamilton J.R. , Parvataneni R. , Stuart S.E. , Chren M.M. .
Source: JAMA dermatology, 2013 May; 149(5), p. 616-8.
PMID: 23677098
Related Citations

Tumor recurrence 5 years after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma.
Authors: Chren M.M. , Linos E. , Torres J.S. , Stuart S.E. , Parvataneni R. , Boscardin W.J. .
Source: The Journal of investigative dermatology, 2013 May; 133(5), p. 1188-96.
EPub date: 2012-11-29.
PMID: 23190903
Related Citations

Recurrence after treatment of cutaneous basal cell and squamous cell carcinomas in patients infected with human immunodeficiency virus.
Authors: Hausauer A.K. , Maurer T. , Leslie K.S. , Parvataneni R. , Stuart S.E. , Chren M.M. .
Source: JAMA dermatology, 2013 Feb; 149(2), p. 239-41.
PMID: 23426494
Related Citations

Fee comparisons of treatments for nonmelanoma skin cancer in a private practice academic setting.
Authors: Wilson L.S. , Pregenzer M. , Basu R. , Bertenthal D. , Torres J. , Asgari M. , Chren M.M. .
Source: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2012 Apr; 38(4), p. 570-84.
EPub date: 2011-12-06.
PMID: 22145798
Related Citations

Recurrence after treatment of nonmelanoma skin cancer: a prospective cohort study.
Authors: Chren M.M. , Torres J.S. , Stuart S.E. , Bertenthal D. , Labrador R.J. , Boscardin W.J. .
Source: Archives of dermatology, 2011 May; 147(5), p. 540-6.
PMID: 21576572
Related Citations

Variation in care for recurrent nonmelanoma skin cancer in a university-based practice and a veterans affairs clinic.
Authors: Clark F.L. , Sahay A. , Bertenthal D. , Maddock L. , Lindquist K. , Grekin R. , Chren M.M. .
Source: Archives of dermatology, 2008 Sep; 144(9), p. 1148-52.
PMID: 18794460
Related Citations




Back to Top